These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 68583)

  • 1. Genetics of cell-mediated lympholysis (CML) determinants: potential for CML typing.
    Long MA; Yunis EJ
    Transplant Proc; 1977 Mar; 9(1):455-7. PubMed ID: 68583
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated lympholysis in man: CML specificities and their possible relevance.
    Kristensen T
    Transplant Proc; 1978 Jun; 10(2):319-25. PubMed ID: 79254
    [No Abstract]   [Full Text] [Related]  

  • 3. The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man.
    Eijsvoogel VP; du Bois MJ; Meinesz A; Bierhorst-Eijlander A; Zeylemaker WP; Schellekens PT
    Transplant Proc; 1973 Dec; 5(4):1675-8. PubMed ID: 4130075
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated lympholysis in dogs: studies of the cytotoxic mechanism.
    Flad HD; Goldmann SF; Krumbacher K; Schnappauf H; Huget RP
    Transplant Proc; 1975 Sep; 7(3):407-10. PubMed ID: 51525
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated lympholysis (CML) in the absence of LD2 mixed lymphocyte reaction and CML in the presence of SD1-SD2 identity in two HL-S-genotyped families.
    Mawas C; Sasportes M; Christen Y; Bernard A; Dausset J; Alter BJ; Bach ML
    Transplant Proc; 1973 Dec; 5(4):1683-9. PubMed ID: 4130077
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-mediated lympholysis in the dog.
    Schroeder ML; Warren RP; Storb R; Goselink H; Johnson S; Brewer M
    Transplant Proc; 1975 Sep; 7(3):411-3. PubMed ID: 51526
    [No Abstract]   [Full Text] [Related]  

  • 7. A new strategy to improve kidney graft survival: the induction of CML nonresponsiveness.
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Gabb BW
    Transplant Proc; 1979 Mar; 11(1):736-42. PubMed ID: 88102
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.
    Miggiano VC; Bernoco D; Lightbody J; Trinchieri G; Ceppellini R
    Transplant Proc; 1972 Jun; 4(2):231-7. PubMed ID: 5034149
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the genetic basis for cell-mediated lympholysis in mice.
    Sorensen SF
    Transplant Proc; 1973 Dec; 5(4):1657-61. PubMed ID: 4130072
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell mediated lympholysis in man after sensitization of effector lymphocytes through mixed leukocyte cultures.
    Lightbody J; Bernoco D; Miggiano VC; Ceppellini R
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):243-54. PubMed ID: 5155939
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen stimulation of human cell-mediated lympholysis suppressor cells in primary and secondary CML.
    Mawas C; Charmot D; Comoy A; Sasportes M
    Transplant Proc; 1977 Mar; 9(1):923-5. PubMed ID: 867508
    [No Abstract]   [Full Text] [Related]  

  • 13. Solubilization of human histocompatibility substances.
    Etheredge EW; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):224-6. PubMed ID: 4106312
    [No Abstract]   [Full Text] [Related]  

  • 14. Carboxyfluorescein fluorochromasis assays for cell-mediated lympholysis (CML) and antibody-dependent cellular cytotoxicity (ADCC): a nonradioactive technique.
    Bruning JW; Kardol MJ; Arentzen R; Naipal A; van der Poel JJ
    Transplant Proc; 1979 Dec; 11(4):1961-3. PubMed ID: 531934
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA restriction of non-HLA--A, --B, --C and --D cell mediated lympholysis (CML).
    Goulmy E; Termijtelen A; Bradley BA; van Rood JJ
    Tissue Antigens; 1976 Nov; 8(5):317-26. PubMed ID: 65023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histocompatibility typing by cell mediated lympholysis (CML): workshop II technical standardization.
    Bradley BA; Charmot D; Goulmy E; Johnsen HE; Kristensen T; Mawas C; Pfeffer P; Schendel D; Wank R
    Tissue Antigens; 1980 Jul; 16(1):73-90. PubMed ID: 6162230
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell mediated lympholysis in man: an attempt to type with cytotoxic lymphocytes.
    Kristensen T; Grunnet N; Jorgensen F; Lamm LU; Kissmeyer-Nielsen F
    Tissue Antigens; 1976 Nov; 8(5):299-316. PubMed ID: 65022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K; Démant P; Festenstein H; Holmes J; Huber B; Rychiková M
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract]   [Full Text] [Related]  

  • 19. The cellular recognition in vitro of antigens related to human histocompatibility.
    Eijsvoogel VP
    Semin Hematol; 1974 Jul; 11(3):305-24. PubMed ID: 4134543
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated lympholysis--problems and possibilities in defining specificities.
    Ward MJ; Stiller CR; McGirr DA; Fung M; Cousin HK; Paty DW; Howson WT; Sinclair NR
    Transplant Proc; 1977 Dec; 9(4):1781-6. PubMed ID: 74884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.